[Synergic effects of lysosome labilizer and anti-neoplastic agents with special reference to the effects of plasmin and mitomycin-C].
D000368:Aged; D000818:Animals; D004357:Drug Synergism; D005260:Female; D005341:Fibrinolysin / Q000008:administration & dosage*; D005343:Fibrinolytic Agents / Q000008:administration & dosage*; D006801:Humans; D008247:Lysosomes / Q000187:drug effects; D008875:Middle Aged; D008937:Mitomycins / Q000008:administration & dosage*; D009369:Neoplasms / Q000188:drug therapy*; D051381:Rats; D012517:Sarcoma, Yoshida / Q000188:drug therapy
D005343:Fibrinolytic Agents; D008937:Mitomycins; D005341:Fibrinolysin